prednisone has been researched along with Dermatitis, Atopic in 35 studies
Prednisone: A synthetic anti-inflammatory glucocorticoid derived from CORTISONE. It is biologically inert and converted to PREDNISOLONE in the liver.
prednisone : A synthetic glucocorticoid drug that is particularly effective as an immunosuppressant, and affects virtually all of the immune system. Prednisone is a prodrug that is converted by the liver into prednisolone (a beta-hydroxy group instead of the oxo group at position 11), which is the active drug and also a steroid.
Dermatitis, Atopic: A chronic inflammatory genetically determined disease of the skin marked by increased ability to form reagin (IgE), with increased susceptibility to allergic rhinitis and asthma, and hereditary disposition to a lowered threshold for pruritus. It is manifested by lichenification, excoriation, and crusting, mainly on the flexural surfaces of the elbow and knee. In infants it is known as infantile eczema.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Thirty-two patients with mild to extensive alopecia areata, including 16 patients with alopecia totalis or universalis, entered a randomized, controlled trial of a 6-week taper of prednisone followed by either 2% topical minoxidil or vehicle applied three times daily for an additional 14 weeks." | 9.07 | Systemic steroids with or without 2% topical minoxidil in the treatment of alopecia areata. ( Carson, SC; Olsen, EA; Turney, EA, 1992) |
| "Thirty-two patients with mild to extensive alopecia areata, including 16 patients with alopecia totalis or universalis, entered a randomized, controlled trial of a 6-week taper of prednisone followed by either 2% topical minoxidil or vehicle applied three times daily for an additional 14 weeks." | 5.07 | Systemic steroids with or without 2% topical minoxidil in the treatment of alopecia areata. ( Carson, SC; Olsen, EA; Turney, EA, 1992) |
| " It is not known how antifolate dose and dosing frequency affect efficacy in AD, but a primary mechanism is thought to involve the antifolate-mediated accumulation of 5-aminoimidazole-4-carboxamide ribonucleotide (AICAR)." | 2.79 | LD-aminopterin in the canine homologue of human atopic dermatitis: a randomized, controlled trial reveals dosing factors affecting optimal therapy. ( Griffin, CE; Kahn, SJ; Messinger, L; Mundell, A; Schuler, AD; Zebala, JA, 2014) |
| " The average daily prednisone dosage was 6." | 2.69 | High dose intravenous immunoglobulin in atopic dermatitis and hyper-IgE syndrome. ( Alazard, M; Saxon, A; Speights, D; Stiehm, ER; Wakim, M; Yajima, A, 1998) |
| "Daily dosage of oral CSA was 3 to 5 mg/kg and mean duration of treatment was 37 months (range, 22-48 months)." | 2.68 | Systemic cyclosporine A in severe atopic keratoconjunctivitis. ( Hannouche, D; Hoang-Xuan, T; Prisant, O; Robin, H, 1997) |
| "Lymphopenia is related to an increased risk of opportunistic infections." | 1.48 | Lymphopenia in atopic dermatitis patients treated with oral immunosuppressive drugs. ( Bakker, DS; Bruijnzeel-Koomen, CAFM; de Bruin-Weller, MS; Garritsen, FM; Leavis, HL; van den Broek, MPH; van der Schaft, J, 2018) |
| "Sarcoidosis is a chronic multisystem disease of unknown origin, which is characterized by T-helper-1 (Th1)-mediated immune responses." | 1.37 | The development of Th1-mediated sarcoidosis improves the clinical course of Th2-mediated atopic dermatitis. ( Asano, Y; Miyagaki, T; Ohno, Y; Saeki, H; Sato, S; Shibata, S; Tamaki, K; Tsunemi, Y, 2011) |
| "She was diagnosed with eczema herpeticum, an uncommon and potentially life-threatening viral infection that arises in areas of pre-existing dermatosis." | 1.35 | Kaposi varicelliform eruption (eczema herpeticum). ( Colven, R; Kirby, P; Olson, J; Robles, DT, 2008) |
| "We suggest that food hypersensitivity should be ruled out in patients with hypereosinophilia, hyper-IgE syndrome, and atopic dermatitis." | 1.35 | Hypereosinophilia, hyper-IgE syndrome, and atopic dermatitis in a toddler with food hypersensitivity. ( Estrada-Reyes, E; Gamboa-Marrufo, JD; Hernnández-Román, MP; Nava-Ocampo, AA; Valencia-Herrera, A, 2008) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 12 (34.29) | 18.7374 |
| 1990's | 4 (11.43) | 18.2507 |
| 2000's | 6 (17.14) | 29.6817 |
| 2010's | 11 (31.43) | 24.3611 |
| 2020's | 2 (5.71) | 2.80 |
| Authors | Studies |
|---|---|
| Perche, PO | 1 |
| Cook, MK | 1 |
| Feldman, SR | 2 |
| Cheirif-Wolosky, O | 1 |
| Elizalde-Jiménez, IG | 1 |
| Romero, MTG | 1 |
| Rutt, VL | 1 |
| Reed, KX | 1 |
| Liu, X | 1 |
| Richard, EG | 1 |
| Purcell, SM | 1 |
| Bakker, DS | 1 |
| Garritsen, FM | 1 |
| Leavis, HL | 1 |
| van der Schaft, J | 1 |
| Bruijnzeel-Koomen, CAFM | 1 |
| van den Broek, MPH | 1 |
| de Bruin-Weller, MS | 1 |
| O'Brien, KF | 1 |
| DeKlotz, CMC | 1 |
| Silverman, RA | 1 |
| Li, J | 1 |
| Luo, X | 1 |
| Ke, H | 1 |
| Liang, L | 1 |
| Zebala, JA | 1 |
| Mundell, A | 1 |
| Messinger, L | 1 |
| Griffin, CE | 1 |
| Schuler, AD | 1 |
| Kahn, SJ | 1 |
| Krejci-Manwaring, J | 1 |
| McCarty, MA | 1 |
| Camacho, F | 1 |
| Manuel, J | 1 |
| Hartle, J | 1 |
| Fleischer, A | 1 |
| Olson, J | 1 |
| Robles, DT | 1 |
| Kirby, P | 1 |
| Colven, R | 1 |
| Miyagaki, T | 1 |
| Asano, Y | 1 |
| Shibata, S | 1 |
| Ohno, Y | 1 |
| Tsunemi, Y | 1 |
| Saeki, H | 1 |
| Tamaki, K | 1 |
| Sato, S | 1 |
| Taszkun, I | 2 |
| Kovalik, M | 1 |
| Pomorski, Z | 1 |
| Kozak, M | 1 |
| Pomorska, D | 1 |
| Szczepanik, M | 1 |
| Wilkolek, P | 1 |
| Palenik, L | 1 |
| Shaw, DJ | 1 |
| van den Broek, AH | 1 |
| Thoday, KL | 1 |
| Sasseville, D | 1 |
| Nantel-Battista, M | 1 |
| Molinari, R | 1 |
| Mathew, SD | 1 |
| Matthews, T | 1 |
| Battafarano, DF | 1 |
| Puya, R | 1 |
| Alvarez-López, M | 1 |
| Velez, A | 1 |
| Casas Asuncion, E | 1 |
| Moreno, JC | 1 |
| BOURGEOIS-SPINASSE, J | 2 |
| REINBERG, A | 2 |
| SIDI, E | 2 |
| ASRILANT, M | 1 |
| KAMINSKY, A | 1 |
| SAENZ, JM | 1 |
| Willemse, T | 1 |
| Wedi, B | 1 |
| Estrada-Reyes, E | 1 |
| Hernnández-Román, MP | 1 |
| Gamboa-Marrufo, JD | 1 |
| Valencia-Herrera, A | 1 |
| Nava-Ocampo, AA | 1 |
| Worm, AM | 1 |
| Rossing, N | 1 |
| Sonenthal, KR | 1 |
| Grammer, LC | 1 |
| Patterson, R | 1 |
| Hoang-Xuan, T | 1 |
| Prisant, O | 1 |
| Hannouche, D | 1 |
| Robin, H | 1 |
| Wakim, M | 1 |
| Alazard, M | 1 |
| Yajima, A | 1 |
| Speights, D | 1 |
| Saxon, A | 1 |
| Stiehm, ER | 1 |
| Wergowske, GL | 1 |
| Fisher, AA | 1 |
| Nesbitt, GH | 1 |
| Olsen, EA | 1 |
| Carson, SC | 1 |
| Turney, EA | 1 |
| Ambrus, JL | 1 |
| Stoll, H | 1 |
| Halpern, J | 1 |
| Klein, E | 1 |
| Wolff, HH | 1 |
| Kutzner, H | 1 |
| Kumar, L | 1 |
| Newcomb, RW | 1 |
| Ishizaka, K | 1 |
| Middleton, E | 1 |
| Hornbrook, MM | 1 |
| Gunnar, S | 1 |
| Johansson, O | 1 |
| Juhlin, L | 1 |
| Wagner, E | 1 |
| Bookman, R | 1 |
| Katz, EE | 1 |
| Thomas, F | 1 |
| Owens, L | 1 |
| Thomas, J | 1 |
| Wolf, JS | 1 |
| Volk, M | 1 |
| Mendez, G | 1 |
| Lee, HM | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Steroid-induced Mood Changes in Patients With Inflammatory Bowel Disease[NCT01981889] | Phase 4 | 53 participants (Actual) | Interventional | 2013-10-31 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
4 reviews available for prednisone and Dermatitis, Atopic
| Article | Year |
|---|---|
Abrocitinib: A New FDA-Approved Drug for Moderate-to-Severe Atopic Dermatitis.
Topics: Adolescent; Biological Products; Cyclosporins; Dermatitis, Atopic; Double-Blind Method; Humans; Immu | 2023 |
Recalcitrant Atopic Keratoconjunctivitis in Children: A Case Report and Literature Review.
Topics: Anti-Inflammatory Agents; Child; Conjunctivitis, Allergic; Dermatitis, Atopic; Humans; Immunosuppres | 2018 |
[Atopic dermatitis in dogs: current knowledge of background and therapeutic possibilities].
Topics: Animals; Anti-Allergic Agents; Dermatitis, Atopic; Dog Diseases; Dogs; Evidence-Based Medicine; Fatt | 2004 |
Urticaria.
Topics: Acute Disease; Anaphylaxis; Angioedema; Chronic Disease; Complement C1 Inhibitor Protein; Dermatitis | 2008 |
5 trials available for prednisone and Dermatitis, Atopic
| Article | Year |
|---|---|
LD-aminopterin in the canine homologue of human atopic dermatitis: a randomized, controlled trial reveals dosing factors affecting optimal therapy.
Topics: Administration, Oral; Aminopterin; Animals; Dermatitis, Atopic; Dogs; Drug Administration Schedule; | 2014 |
Topical tacrolimus 0.1% improves symptoms of hand dermatitis in patients treated with a prednisone taper.
Topics: Administration, Oral; Administration, Topical; Adult; Aged; Dermatitis, Atopic; Dermatitis, Contact; | 2008 |
Systemic cyclosporine A in severe atopic keratoconjunctivitis.
Topics: Administration, Oral; Adult; Anti-Inflammatory Agents; Conjunctivitis, Allergic; Cyclosporine; Derma | 1997 |
High dose intravenous immunoglobulin in atopic dermatitis and hyper-IgE syndrome.
Topics: Adolescent; Adult; Antibodies; Antigens, CD; B-Lymphocytes; CD40 Antigens; Cells, Cultured; Child; D | 1998 |
Systemic steroids with or without 2% topical minoxidil in the treatment of alopecia areata.
Topics: Administration, Cutaneous; Administration, Oral; Adolescent; Adult; Alopecia Areata; Child; Dermatit | 1992 |
26 other studies available for prednisone and Dermatitis, Atopic
| Article | Year |
|---|---|
Systemic treatment for severe atopic dermatitis in children: a case series.
Topics: Azathioprine; Child; Child, Preschool; Cyclosporine; Dermatitis, Atopic; Humans; Methotrexate; Mycop | 2022 |
Photosensitive atopic dermatitis exacerbated by UVB exposure.
Topics: Anti-Inflammatory Agents; Dermatitis, Atopic; Diagnosis, Differential; Enzyme Inhibitors; Female; Hu | 2017 |
Lymphopenia in atopic dermatitis patients treated with oral immunosuppressive drugs.
Topics: Administration, Oral; Adult; CD4-Positive T-Lymphocytes; CD8-Positive T-Lymphocytes; Dermatitis, Ato | 2018 |
Exogenous Cushing syndrome from an unexpected source of systemic steroids.
Topics: Child; Cushing Syndrome; Dermatitis, Atopic; Glucocorticoids; Humans; Male; Prednisolone; Prednisone | 2018 |
Kaposi varicelliform eruption (eczema herpeticum).
Topics: Acyclovir; Adult; Antiviral Agents; Codeine; Dermatitis, Allergic Contact; Dermatitis, Atopic; Diagn | 2008 |
The development of Th1-mediated sarcoidosis improves the clinical course of Th2-mediated atopic dermatitis.
Topics: Adult; Biopsy; Dermatitis, Atopic; Humans; Male; Prednisone; Sarcoidosis; Th1 Cells; Th2 Cells; Tomo | 2011 |
The evaluation of Canine Atopic Dermatitis Extent and Severity Index (CADESI) test in dogs with atopic dermatitis (AD) treated with cyclosporine or prednisone.
Topics: Animals; Cyclosporine; Dermatitis, Atopic; Dog Diseases; Dogs; Female; Immunosuppressive Agents; Mal | 2010 |
Evaluation of a human generic formulation of ciclosporin in the treatment of canine atopic dermatitis with in vitro assessment of the functional capacity of phagocytic cells.
Topics: Animals; Cyclosporine; Dermatitis, Atopic; Dermatologic Agents; Dog Diseases; Dogs; Female; Humans; | 2011 |
Multiple contact allergies to benzophenones.
Topics: Benzophenones; Dermatitis, Atopic; Dermatitis, Photoallergic; Dermatologic Agents; Humans; Male; Mid | 2011 |
Systemic vasculitis in a patient with atopic dermatitis, eosinophilia, pulmonary-renal syndrome, and positive myeloperoxidase antibody: a classification conundrum.
Topics: Aged; Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis; Antirheumatic Agents; Chronic Dise | 2012 |
Treatment of severe refractory adult atopic dermatitis with ustekinumab.
Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Cyclosporine; Dermatitis, Atopic; Eczema; | 2012 |
[Delta-1-dehydrocortisone in the treatment of allergic dermatosis].
Topics: Dermatitis; Dermatitis, Atopic; Dermatitis, Contact; Humans; Prednisone | 1956 |
[Delta-1-dehydrocortisone in the treatment of allergic dermatosis].
Topics: Dermatitis; Dermatitis, Atopic; Dermatitis, Contact; Humans; Prednisone | 1956 |
[Delta-1-dehydrocortisone in the treatment of allergic dermatosis].
Topics: Dermatitis; Dermatitis, Atopic; Dermatitis, Contact; Humans; Prednisone | 1956 |
[Delta-1-dehydrocortisone in the treatment of allergic dermatosis].
Topics: Dermatitis; Dermatitis, Atopic; Dermatitis, Contact; Humans; Prednisone | 1956 |
[Therapeutic activity of triamcinolone in atopic dermatitis: comparative trials with prednisone & prednisolone].
Topics: Dermatitis, Atopic; Eczema; Fludrocortisone; Prednisolone; Prednisone; Triamcinolone | 1959 |
Hypereosinophilia, hyper-IgE syndrome, and atopic dermatitis in a toddler with food hypersensitivity.
Topics: Azathioprine; Bone Marrow Examination; Cell Separation; Combined Modality Therapy; Dermatitis, Atopi | 2008 |
Microvascular protein leakage in extensive skin diseases: aspects of the transport mechanisms.
Topics: Adult; Aged; Albumins; Biological Transport; Capillary Permeability; Dermatitis, Atopic; Dermatitis, | 1980 |
Do some patients with atopic dermatitis require long-term oral steroid therapy?
Topics: Administration, Oral; Adult; Child; Dermatitis, Atopic; Drug Administration Schedule; Female; Humans | 1993 |
Treatment-resistant atopic dermatitis.
Topics: Acetates; Aged; Aged, 80 and over; Anti-Inflammatory Agents; Antipruritics; Cyclopropanes; Dermatiti | 2001 |
Suppression of reactions to certain cosmetics.
Topics: Aldehydes; Animals; Coloring Agents; Cosmetics; Dermatitis, Atopic; Diamines; Female; Guinea Pigs; H | 1977 |
Canine allergic inhalant dermatitis: a review of 230 cases.
Topics: Allergens; Animals; Dermatitis, Atopic; Desensitization, Immunologic; Dog Diseases; Dogs; Female; Ma | 1978 |
Meclomen potentiates dermatologic effects of steroids.
Topics: Dermatitis, Atopic; Drug Synergism; Drug Therapy, Combination; Humans; Male; Meclofenamic Acid; Midd | 1986 |
[How do I treat dyshidrosiform eruptions?].
Topics: Combined Modality Therapy; Dermatitis, Atopic; Dermatitis, Contact; Foot Dermatoses; Hand Dermatoses | 1986 |
IgE levels in sera of children with asthma.
Topics: Adolescent; Allergens; Asthma; Bronchodilator Agents; Child; Dermatitis, Atopic; Female; gamma-Globu | 1971 |
Immunoglobulin E in "healed" atopic dermatitis and after treatment with corticosteroids and azathioprine.
Topics: Adolescent; Adult; Aged; Azathioprine; Dermatitis, Atopic; Eczema; Female; gamma-Globulins; Humans; | 1970 |
[The behavior of blood eosinophils in infants during clinical treatment of eczema].
Topics: Dermatitis, Atopic; Dermatitis, Seborrheic; Eosinophilia; Humans; Infant; Prednisone | 1969 |
ACTH and steroids: their use in the practice of allergy.
Topics: Adolescent; Adrenal Cortex Hormones; Adrenocorticotropic Hormone; Adult; Aged; Angioedema; Asthma; C | 1966 |
Differential effect of immunosuppressive agents on T and B lymphocytes.
Topics: Animals; Antilymphocyte Serum; Azathioprine; B-Lymphocytes; Bacterial Infections; Concanavalin A; De | 1974 |